Results 121 to 130 of about 16,858 (143)

Clinical Utility of the Anti‐CCP Assay: Experiences with 700 Patients

Annals of the New York Academy of Sciences, 2005
Abstract: Our objective was to determine the frequency of antibodies to cyclic citrullinated peptides (CCPs) in a series of patients with a variety of rheumatic diseases. Seven hundred consecutive serum samples from patients at an outpatient clinic were tested for the presence of rheumatoid factor (RF) and anti‐CCP.
Ulrich, Sauerland, Heidemarie, Becker, Matthias, Seidel, Heiko, Schotte, Peter, Willeke, Annette, Schorat, Bernhard, Schlüter, Wolfram, Domschke, Markus, Gaubitz   +8 more
openaire   +2 more sources

Whither Autoimmunity: The Lessons of Anti-CCP and B cell Depletion

Clinical Reviews in Allergy & Immunology, 2007
The most difficult component to understand in autoimmune disease has been the issue of causation. In contrast, there have been enormous gains in improved diagnostics as well as improved therapy. Indeed, the use of biologics have changed the profile of numerous autoimmune diseases. In this issue, we discuss two such aspects.
Yehuda, Shoenfeld, M Eric, Gershwin
openaire   +2 more sources

Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper

Autoimmunity Reviews, 2010
Rheumatoid arthritis (RA) is a crippling joint disease affecting over 20 million people worldwide. The cause of RA is most probably linked to the triad of microbial trigger, genetic association and autoimmunity and can be explained using the philosophical method of Karl Popper or Popperian sequences.
Ebringer, Alan, Rashid, Taha, Wilson, Clyde   +2 more
openaire   +3 more sources

Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis

Rheumatology International, 2013
Anti-cyclic citrullinated peptide (anti-CCP) was positive in 11.5 % and rheumatoid factor was positive in 8.8 % of the patients with Brucella. After a comparative evaluation, we have found out that there was not a statistical significance concerning the anti-CCP levels between the patients with brucellosis and healthy control.
Pehlivan, YAVUZ, Onat, Ahmet Mesut, Sayarlioglu, Mehmet, Devay, Seda Duygulu, Aydinli, Musa, Mercan, Ozge Kaya, Ugurlu, Kenan, Dag, Muhammet Said, Kisacik, Bunyamin   +8 more
openaire   +3 more sources

High positivity of anti-CCP antibodies in patients with Down syndrome

Clinical Rheumatology, 2007
The aim of the present study was to evaluate the prevalence of anti-cyclic citrullinated peptide (CCP) antibodies in patients with Down's syndrome (DS) previously tested for IgM rheumatoid factor (RF) and to correlate the results with clinical findings.
Renato M, Nisihara, Thelma L, Skare, Marília B G, Silva, Iara T, Messias-Reason, Nanci P, Oliveira, Patricia T, Fiedler, Shirley R R, Utiyama   +6 more
openaire   +2 more sources

Association of anti-CCP positivity with serum ferritin and DAS-28

Rheumatology International, 2009
Antibodies to cyclic citrullinated peptides (anti-CCP) are highly specific for the diagnosis of rheumatoid arthritis (RA) with a marginal increased prediction of the disease. In this study, we aimed to investigate the relation of the presence of anti-CCP with clinical manifestations and disease activity in a cohort of RA patients.
Burcu, Önder, Aydan, Kurtaran, Songül, Kimyon, Barin, Selçuk, Müfit, Akyüz   +4 more
openaire   +2 more sources

Anti-CCP og reumatoid artrit

2007
Udgivelsesdato ...
Grinsted, Per, Junker, Peter, Lillevang, Søren Thue   +2 more
openaire   +1 more source

Anti-CCP antibodies as a marker of rhupus

Lupus, 2015
J, Amaya-Amaya, N, Molano-González, J-S, Franco, M, Rodríguez-Jiménez, A, Rojas-Villarraga, J-M, Anaya   +5 more
openaire   +2 more sources

BioPlex Anti-CCP Kits

Biomedical Safety & Standards, 2023
openaire   +1 more source

Anti-CCP abs in the management and pathogenesis of RA

2004
Item does not contain ...
Venrooij, W.J.W. van, Vossenaar, E.R.
openaire   +1 more source